Related references
Note: Only part of the references are listed.Cancer Statistics, 2015
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Genomic, pathological, and clinical heterogeneity as drivers of personalized medicine in prostate cancer
Michael Fraser et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2015)
Cytotoxic and DNA-Targeted Therapy in Urothelial Cancer
Arjun V. Balar et al.
CANCER (2015)
Glycogen storage disease type III: A novel Agl knockout mouse model
Serena Pagliarani et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
Increased sensitivity to glucose starvation correlates with downregulation of glycogen phosphorylase isoform PYGB in tumor cell lines resistant to 2-deoxy-d-glucose
Katherine B. Philips et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2014)
Chemotherapeutic and targeted biological agents for metastatic bladder cancer: A comprehensive review
Terence T. Sio et al.
INTERNATIONAL JOURNAL OF UROLOGY (2014)
Role in Tumor Growth of a Glycogen Debranching Enzyme Lost in Glycogen Storage Disease
Sunny Guin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Mouse model of glycogen storage disease type III
Kai-Ming Liu et al.
MOLECULAR GENETICS AND METABOLISM (2014)
Rare insights into cancer biology
J. Adam et al.
ONCOGENE (2014)
Phenotypic drug screening and target validation for improved personalized therapy reveal the complexity of phenotype-genotype correlations in clear cell renal cell carcinoma
Meike Schneider et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)
KIAA1199 interacts with glycogen phosphorylase kinase β-subunit (PHKB) to promote glycogen breakdown and cancer cell survival
Masato Terashima et al.
ONCOTARGET (2014)
Genomic analysis as the first step toward personalized treatment in renal cell carcinoma
Zofia Felicia Bielecka et al.
FRONTIERS IN ONCOLOGY (2014)
Molecular Pathways: Fumarate Hydratase-Deficient Kidney Cancer-Targeting the Warburg Effect in Cancer
W. Marston Linehan et al.
CLINICAL CANCER RESEARCH (2013)
Neuromuscular Disorders of Glycogen Metabolism
Elisabetta Gazzerro et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2013)
ICUD-EAU International Consultation on Bladder Cancer 2012: Chemotherapy for Urothelial Carcinoma-Neoadjuvant and Adjuvant Settings
Cora N. Sternberg et al.
EUROPEAN UROLOGY (2013)
Glycogen phosphorylase inhibitors: a patent review (2008-2012)
Nicolas Gaboriaud-Kolar et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2013)
Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I
Julien Calderaro et al.
JOURNAL OF HEPATOLOGY (2013)
Personalized medicine for targeted and platinum-based chemotherapy of lung and bladder cancer
George D. Cimino et al.
BIOANALYSIS (2013)
Targeting cellular metabolism to improve cancer therapeutics
Y. Zhao et al.
CELL DEATH & DISEASE (2013)
Non-glucose metabolism in cancer cells-is it all in the fat?
Swethajit Biswas et al.
CANCER AND METASTASIS REVIEWS (2012)
Glucose Utilization via Glycogen Phosphorylase Sustains Proliferation and Prevents Premature Senescence in Cancer Cells
Elena Favaro et al.
CELL METABOLISM (2012)
Emerging personalized approaches for the management of advanced urothelial carcinoma
Che-Kai Tsao et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2012)
Targeting of Several Glycolytic Enzymes Using RNA Interference Reveals Aldolase Affects Cancer Cell Proliferation through a Non-glycolytic Mechanism
Carolyn Ritterson Lew et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Phase 2 Study of Adjuvant Intravesical Instillations of Apaziquone for High Risk Nonmuscle Invasive Bladder Cancer
K. Hendricksen et al.
JOURNAL OF UROLOGY (2012)
A Small-Molecule Inhibitor of Glucose Transporter 1 Downregulates Glycolysis, Induces Cell-Cycle Arrest, and Inhibits Cancer Cell Growth In Vitro and In Vivo
Yi Liu et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Inhibition of Glycogen Phosphorylation Induces Changes in Cellular Proteome and Signaling Pathways in MIA Pancreatic Cancer Cells
Danjun Ma et al.
PANCREAS (2012)
Metabolite Profiling Identifies a Key Role for Glycine in Rapid Cancer Cell Proliferation
Mohit Jain et al.
SCIENCE (2012)
Glycogen synthesis is induced in hypoxia by the hypoxia-inducible factor and promotes cancer cell survival
Joffrey Pelletier et al.
FRONTIERS IN ONCOLOGY (2012)
Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells
Lisa S. Pike et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2011)
IKKβ and NF-κB Transcription Govern Lymphoma Cell Survival through AKT-Induced Plasma Membrane Trafficking of GLUT1
Thomas G. Sommermann et al.
CANCER RESEARCH (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Therapeutic targeting of cancer cell metabolism
Chi V. Dang et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2011)
HIF-1 as a Target for Cancer Chemotherapy, Chemosensitization and Chemoprevention
Elena Monti et al.
Current Molecular Pharmacology (2011)
A phase I clinical trial of FOLFIRI in combination with the pan-cyclin-dependent kinase (CDK) inhibitor flavopiridol
Mark A. Dickson et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Monoacylglycerol Lipase Regulates a Fatty Acid Network that Promotes Cancer Pathogenesis
Daniel K. Nomura et al.
CELL (2010)
Glycogen Storage Disease Type III diagnosis and management guidelines
Priya S. Kishnani et al.
GENETICS IN MEDICINE (2010)
The genetic basis of kidney cancer: a metabolic disease
W. Marston Linehan et al.
NATURE REVIEWS UROLOGY (2010)
Hypoxia Promotes Glycogen Accumulation through Hypoxia Inducible Factor (HIF)-Mediated Induction of Glycogen Synthase 1
Nuria Pescador et al.
PLOS ONE (2010)
Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression
Anne Le et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
AMP-activated protein kinase - a sensor of glycogen as well as AMP and ATP?
A. McBride et al.
ACTA PHYSIOLOGICA (2009)
De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy
T. Mashima et al.
BRITISH JOURNAL OF CANCER (2009)
Phosphoglucose Isomerase/Autocrine Motility Factor Mediates Epithelial and Mesenchymal Phenotype Conversions in Breast Cancer
Tatsuyoshi Funasaka et al.
CANCER RESEARCH (2009)
Abnormalities in Glucose Uptake and Metabolism in Imatinib-Resistant Human BCR-ABL-Positive Cells
Douglas J. Kominsky et al.
CLINICAL CANCER RESEARCH (2009)
Chromosomal and genetic alterations in human hepatocellular adenomas associated with type Ia glycogen storage disease
Priya S. Kishnani et al.
HUMAN MOLECULAR GENETICS (2009)
SHMT1 and SHMT2 Are Functionally Redundant in Nuclear De novo Thymidylate Biosynthesis
Donald D. Anderson et al.
PLOS ONE (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
Stable RNA interference of hexokinase II gene inhibits human colon cancer LoVo cell growth in vitro and in vivo
Qiuping Peng et al.
CANCER BIOLOGY & THERAPY (2008)
Tumor cell metabolism: Cancer's Achilles' heel
Guido Kroemer et al.
CANCER CELL (2008)
Roles of p53, Myc and HIF-1 in Regulating Glycolysis - the Seventh Hallmark of Cancer
S. J. Yeung et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Pyruvate kinase isozyme type M2 (PKM2) interacts and cooperates with Oct-4 in regulating transcription
Jungwoon Lee et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
Hyperlipidemia in glycogen storage disease type III: Effect of age and metabolic control
A. V. Bernier et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2008)
Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth
Brian Clem et al.
MOLECULAR CANCER THERAPEUTICS (2008)
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Heather R. Christofk et al.
NATURE (2008)
Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis
Ralph J. DeBerardinis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
A role for AGL ubiquitination in the glycogen storage disorders of Lafora and Cori's disease
Alan Cheng et al.
GENES & DEVELOPMENT (2007)
Expression of GLUT1 in primary renal tumors - Morphologic and biologic implications
Ayhan Ozcan et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2007)
Does increased fatty acid oxidation enhance development of liver cirrhosis and progression to hepatocellular carcinoma in patients with glycogen storage disease type-III?
Hilde Herrema et al.
JOURNAL OF HEPATOLOGY (2007)
Glycogen storage disease type III-hepatocellular carcinoma a long-term complication?
Erin Demo et al.
JOURNAL OF HEPATOLOGY (2007)
Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia
Xianhua Cao et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2007)
Energy metabolism in tumor cells
Rafael Moreno-Sanchez et al.
FEBS JOURNAL (2007)
Glycolysis inhibition for anticancer treatment
H. Pelicano et al.
ONCOGENE (2006)
Fatty acid synthase and cancer: New application of an old pathway
FP Kuhajda
CANCER RESEARCH (2006)
Determining and understanding the control of glycolysis in fast-growth tumor cells -: Flux control by an over-expressed but strongly product-inhibited hexokinase
A Marín-Hernández et al.
FEBS JOURNAL (2006)
Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance
Valeria R. Fantin et al.
CANCER CELL (2006)
ATP citrate lyase inhibition can suppress tumor cell growth
G Hatzivassiliou et al.
CANCER CELL (2005)
Glycogen debranching enzyme association with β-subunit regulates AMP-activated protein kinase activity
H Sakoda et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: Novel role of fumarate in regulation of HIF stability
JS Isaacs et al.
CANCER CELL (2005)
A phase II study of flavopiridol in patients with advanced renal cell carcinoma: results of Southwest Oncology Group Trial 0109
PJ Van Veldhuizen et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2005)
Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer
ML Macheda et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2005)
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase
MA Selak et al.
CANCER CELL (2005)
Glucose transporter-1 expression in urothelial papilloma of the bladder
JH Lee et al.
UROLOGIA INTERNATIONALIS (2005)
A Phase II trial of flavopiridol (NSC #649890) in patients with previously untreated metastatic androgen-independent prostate cancer
G Liu et al.
CLINICAL CANCER RESEARCH (2004)
Metabolic sensitivity of pancreatic tumour cell apoptosis to glycogen phosphorylase inhibitor treatment
WNP Lee et al.
BRITISH JOURNAL OF CANCER (2004)
2-deoxy-D-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo
G Maschek et al.
CANCER RESEARCH (2004)
GLUTI and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON
PJ Hoskin et al.
BRITISH JOURNAL OF CANCER (2003)
Inhibition of glycogen phosphorylase (GP) by CP-91,149 induces growth inhibition correlating with brain GP expression
JB Schnier et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Understanding the tumor metabolic phenotype in the genomic era
M Stubbs et al.
CURRENT MOLECULAR MEDICINE (2003)
Increased fatty acid synthase as a therapeutic target in androgen-independent prostate cancer progression
ES Pizer et al.
PROSTATE (2001)
The cyclin-dependent kinase (CDK) inhibitor flavopiridol inhibits glycogen phosphorylase
A Kaiser et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2001)
Hepatocellular carcinoma complicating liver cirrhosis in type IIIa glycogen storage disease
M Siciliano et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2000)
A new allosteric site in glycogen phosphorylase b as a target for drug interactions
NG Oikonomakos et al.
STRUCTURE (2000)
Expression of the human erythrocyte glucose transporter in transitional cell carcinoma of the bladder
SG Chang et al.
UROLOGY (2000)
Share Paper
